Diurnal growth hormone and glucose abnormalities in unstable diabetics: Studies of ambulatory-fed subjects during continuous blood glucose analysis

George D. Molnar, William F. Taylor, Alice Langworthy, Vahab Fatourechi

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

Blood glucose (BG) was monitored continuously and plasma growth hormone (hGH) was determined at hourly intervals in patients under standardized ambulatory-fed conditions (48- hr study periods after prolonged preparation for optimal therapy). BG regulatory stability was quantified on the basis of mean amplitude of glycemic excursions (MAGE, a measure of withinday BG variability), mean of daily differences of matched BG values on successive days (MODD, a measure of between-day BG variability), and mean BG (MBG, a measure of diurnal glycemia). Eight unstable diabetics, all with high BG parameters, also had high mean hourly hGH and peak hGH values compared with three stable diabetics and three normal subjects. While inadvertent hypoglycemic episodes and exercise-related and sleep-related hGH increases contributed to the higher hGH levels in the unstable diabetics, none of these events accounted for the observed differences. In this study, diabetic instability and sex were found to exert significant effects. At the time of hGH increases, BG concentrations were consistently higher in diabetics than in normals. A lower mean glycemia in unstable diabetics (during intensified therapy with 4 daily injections of short-acting insulin, compared with 1 or 2 daily injections of intermediate-acting insulin) did not lower the mean level of hourly hGH values nor the mean height of the hGH peaks. However, the MAGE and MODD values also were not decreased by such intensified insulin therapy. Higher than normal diurnal hGH levels exist in unstable diabetics even under apparently optimal therapeutic conditions.

Original languageEnglish (US)
Pages (from-to)837-846
Number of pages10
JournalJournal of Clinical Endocrinology and Metabolism
Volume34
Issue number5
DOIs
StatePublished - Jan 1 1972

Fingerprint

Growth Hormone
Blood Glucose
Glucose
Short-Acting Insulin
Insulin
Injections
Therapeutics
Hypoglycemic Agents
Sleep
Exercise
Plasmas

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Endocrinology
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Diurnal growth hormone and glucose abnormalities in unstable diabetics : Studies of ambulatory-fed subjects during continuous blood glucose analysis. / Molnar, George D.; Taylor, William F.; Langworthy, Alice; Fatourechi, Vahab.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 34, No. 5, 01.01.1972, p. 837-846.

Research output: Contribution to journalArticle

@article{673fc193f3f347188f203b683fb11365,
title = "Diurnal growth hormone and glucose abnormalities in unstable diabetics: Studies of ambulatory-fed subjects during continuous blood glucose analysis",
abstract = "Blood glucose (BG) was monitored continuously and plasma growth hormone (hGH) was determined at hourly intervals in patients under standardized ambulatory-fed conditions (48- hr study periods after prolonged preparation for optimal therapy). BG regulatory stability was quantified on the basis of mean amplitude of glycemic excursions (MAGE, a measure of withinday BG variability), mean of daily differences of matched BG values on successive days (MODD, a measure of between-day BG variability), and mean BG (MBG, a measure of diurnal glycemia). Eight unstable diabetics, all with high BG parameters, also had high mean hourly hGH and peak hGH values compared with three stable diabetics and three normal subjects. While inadvertent hypoglycemic episodes and exercise-related and sleep-related hGH increases contributed to the higher hGH levels in the unstable diabetics, none of these events accounted for the observed differences. In this study, diabetic instability and sex were found to exert significant effects. At the time of hGH increases, BG concentrations were consistently higher in diabetics than in normals. A lower mean glycemia in unstable diabetics (during intensified therapy with 4 daily injections of short-acting insulin, compared with 1 or 2 daily injections of intermediate-acting insulin) did not lower the mean level of hourly hGH values nor the mean height of the hGH peaks. However, the MAGE and MODD values also were not decreased by such intensified insulin therapy. Higher than normal diurnal hGH levels exist in unstable diabetics even under apparently optimal therapeutic conditions.",
author = "Molnar, {George D.} and Taylor, {William F.} and Alice Langworthy and Vahab Fatourechi",
year = "1972",
month = "1",
day = "1",
doi = "10.1210/jcem-34-5-837",
language = "English (US)",
volume = "34",
pages = "837--846",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "5",

}

TY - JOUR

T1 - Diurnal growth hormone and glucose abnormalities in unstable diabetics

T2 - Studies of ambulatory-fed subjects during continuous blood glucose analysis

AU - Molnar, George D.

AU - Taylor, William F.

AU - Langworthy, Alice

AU - Fatourechi, Vahab

PY - 1972/1/1

Y1 - 1972/1/1

N2 - Blood glucose (BG) was monitored continuously and plasma growth hormone (hGH) was determined at hourly intervals in patients under standardized ambulatory-fed conditions (48- hr study periods after prolonged preparation for optimal therapy). BG regulatory stability was quantified on the basis of mean amplitude of glycemic excursions (MAGE, a measure of withinday BG variability), mean of daily differences of matched BG values on successive days (MODD, a measure of between-day BG variability), and mean BG (MBG, a measure of diurnal glycemia). Eight unstable diabetics, all with high BG parameters, also had high mean hourly hGH and peak hGH values compared with three stable diabetics and three normal subjects. While inadvertent hypoglycemic episodes and exercise-related and sleep-related hGH increases contributed to the higher hGH levels in the unstable diabetics, none of these events accounted for the observed differences. In this study, diabetic instability and sex were found to exert significant effects. At the time of hGH increases, BG concentrations were consistently higher in diabetics than in normals. A lower mean glycemia in unstable diabetics (during intensified therapy with 4 daily injections of short-acting insulin, compared with 1 or 2 daily injections of intermediate-acting insulin) did not lower the mean level of hourly hGH values nor the mean height of the hGH peaks. However, the MAGE and MODD values also were not decreased by such intensified insulin therapy. Higher than normal diurnal hGH levels exist in unstable diabetics even under apparently optimal therapeutic conditions.

AB - Blood glucose (BG) was monitored continuously and plasma growth hormone (hGH) was determined at hourly intervals in patients under standardized ambulatory-fed conditions (48- hr study periods after prolonged preparation for optimal therapy). BG regulatory stability was quantified on the basis of mean amplitude of glycemic excursions (MAGE, a measure of withinday BG variability), mean of daily differences of matched BG values on successive days (MODD, a measure of between-day BG variability), and mean BG (MBG, a measure of diurnal glycemia). Eight unstable diabetics, all with high BG parameters, also had high mean hourly hGH and peak hGH values compared with three stable diabetics and three normal subjects. While inadvertent hypoglycemic episodes and exercise-related and sleep-related hGH increases contributed to the higher hGH levels in the unstable diabetics, none of these events accounted for the observed differences. In this study, diabetic instability and sex were found to exert significant effects. At the time of hGH increases, BG concentrations were consistently higher in diabetics than in normals. A lower mean glycemia in unstable diabetics (during intensified therapy with 4 daily injections of short-acting insulin, compared with 1 or 2 daily injections of intermediate-acting insulin) did not lower the mean level of hourly hGH values nor the mean height of the hGH peaks. However, the MAGE and MODD values also were not decreased by such intensified insulin therapy. Higher than normal diurnal hGH levels exist in unstable diabetics even under apparently optimal therapeutic conditions.

UR - http://www.scopus.com/inward/record.url?scp=0015337520&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0015337520&partnerID=8YFLogxK

U2 - 10.1210/jcem-34-5-837

DO - 10.1210/jcem-34-5-837

M3 - Article

C2 - 5012495

AN - SCOPUS:0015337520

VL - 34

SP - 837

EP - 846

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 5

ER -